Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease - Top-Institutions - MDSpire

Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease

  • By

  • Jie Su

  • Dalia A Lartey

  • Gaia Zanella

  • Lukas J A C Hawinkels

  • Gianluca Matteoli

  • Mark Löwenberg

  • Marieke C Barnhoorn

  • May 24, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Clinical Research

  • #2

    Mount Sinai Hospital - Icahn School of Medicine
    Mount Sinai Hospital - Icahn School of Medicine

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Translational Medicine

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Fibrosis Research

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Clinical Trials

Original Source(s)

Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease

  • by Jie Su, Dalia A Lartey, Gaia Zanella, Lukas J A C Hawinkels, Gianluca Matteoli, Mark Löwenberg, Marieke C Barnhoorn

  • May 24, 2025

Related Content

Pregnane X receptor (NR1I2) deficiency in mice reveals context-dependent regulation of inflammatory homeostasis

Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Evaluation of Tacrolimus in Ulcerative Colitis: A Retrospective Analysis of Factors Influencing Remission Induction and Maintenance